Skip to main content
Fig. 9 | Journal of Ovarian Research

Fig. 9

From: Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer

Fig. 9

In vitro validation of rapamycin in OC cell lines. A Differences in drug sensitivity of rapamycin between high- and low-risk groups. B MTT assay, C transwell assay, and D gap closure analysis were performed in SKOV3 cell line after treated with rapamycin at the concentration of 20um. E MTT assay, F transwell assay, and G gap closure analysis were also performed in A2780 cell line after treated with rapamycin at the concentration of 20um. NC, Normal Control

Back to article page